AJR AJR-based Continuing Ed for Technologists
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guzmán-de-Villoria, J. A.
Right arrow Articles by Desco, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guzmán-de-Villoria, J. A.
Right arrow Articles by Desco, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
DOI:10.2214/AJR.06.0055
AJR 2007; 188:710-714
© American Roentgen Ray Society


Original Research

1H MR Spectroscopy in the Assessment of Gliomatosis Cerebri

Juan A. Guzmán-de-Villoria1, Javier Sánchez-González2, Lucia Muñoz1, Santiago Reig2, Carlos Benito3, Pedro García-Barreno2 and Manuel Desco2

1 Department of Neuroradiology, Hospital General Universitario Gregorio Marañón, Madrid, Spain 28007.
2 Unidad de Medicina y Cirgugía Experimental, Hospital General Universitario Gregorio Marañón, C/Dr. Esquerdo 46, Madrid, Spain 28007.
3 Department of Radiology, Hospital General Universitario Gregorio Marañón, Madrid, Spain 28007.

OBJECTIVE. Gliomatosis cerebri is a rare brain tumor with a short survival time; for this reason, it is difficult to establish the degree of aggressivity in vivo. The MR spectroscopic findings on this tumor often do not agree with choline level. The purpose of this study was to evaluate whether MR spectroscopy can be used to measure tumor choline levels and whether the findings give useful information about tumor growth rate and patient survival time.

SUBJECTS AND METHODS. We performed MRI and 1H MR spectroscopic studies on seven treatment-naive patients with gliomatosis cerebri and on 16 healthy volunteers. We then analyzed the association between survival time and levels of choline (Cho) and N-acetyl aspartate (NAA) normalized to creatine (Cr).

RESULTS. The results showed a statistically significant (p = 0.05) inverse relation between Cho/Cr ratio and survival time. In addition, NAA/Cr ratio was significantly lower in the patient group than in the control group (p = 0.001).

CONCLUSION. Cho/Cr ratio measured with MR spectroscopy seems to be related to survival time, possibly explaining the inconsistent findings previously reported for this parameter.

Keywords: brain • gliomatosis cerebri • MRI technique • MR spectroscopy


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
NeurologyHome page
J. O. Fleming, B. M. Keegan, and J. E. Parisi
A 52-year-old man with progressive left-sided weakness and white matter disease
Neurology, August 7, 2007; 69(6): 600 - 606.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Roentgen Ray Society.